PharmEng Announces Organizational Restructuring

TORONTO, ONTARIO--(Marketwire - December 11, 2008) - PharmEng International Inc. (TSX VENTURE: PII), a full-service consulting and contract manufacturing company, today announced, as a result of a corporate realignment, that David Leonard, President, Keata Sydney has left the organization to pursue other interests. "On behalf of the Company, I would like to thank David for his service and leadership at Keata, during which time Keata designed, constructed and successfully commissioned the pharmaceutical manufacturing facility in Sydney. This realignment reflects our continued efforts to streamline our contract manufacturing operations while we complete our strategic assessment of the Sydney facility. We wish David well in his future endeavors," stated Alan Kwong, CEO of PharmEng International Inc.